Nanjing Kingfriend integrates drug research and development, production and sales.
Listed on SSE A share on 19th July, 2017, Kingfriend has, not only the world’s leading isolator production line and advanced aseptic injection production technology, but also a globalized quality system, approved by many countries and regions, including China, the United States, Europe, Japan and Brazil, etc. With a world-class production research and development speed and the globalized quality awareness, we have the sales capability that make us take root in the U.S. market. Besides, injectable CDMO service, covering the global market while targeting at China and US markets’, can be provided by us. By attracting and recruiting talents from all over the globe, our newly established bio-innovative pharmaceuticals business department aims at becoming an innovative and international biopharmaceutical company that is superior in pharmaceutical field.